A clinical study published in PNAS provides further proof-of-concept that beta cell encapsulation holds real promise for making islet implantation a viable therapy for people with type 1 diabetes (T1D).
Welcome to our final daily summary of type 1 diabetes (T1D) research highlights from the ADA’s 73rd Scientific Sessions! Each night, we have been posting summaries of notable sessions and presentations. Below are two relevant sessions from Monday, June 24: From Mice to Men and Back in Diabetic Kidney Disease Diabetic kidney disease remains one of […]
Welcome to our daily summary of type 1 diabetes (T1D) research highlights from the ADA’s 73rd Scientific Sessions! Each night, we will be posting summaries of notable sessions and presentations. Below are two relevant sessions from Friday, June 21. Beta Cell Failure in Type 1 Diabetes – Cause or Consequences? The fact that T1D is a complicated […]
JDRF-supported research is at the forefront of the American Diabetes Association’s (ADA) 73rd Scientific Sessions this year, June 21-24 in Chicago, with 13 oral presentations, 14 poster presentations, three symposium discussions, one scientific workshop, more than a dozen meetings with research partners, and 20 JDRF staff and senior leadership in attendance to represent scientific progress […]
JDRF recently brought together a group of 20 leading experts in the behavioral and mental health fields to discuss the range of psychological and social issues experienced by people with type 1 diabetes (T1D) and their families. Forums like this enable JDRF to stay up-to-date with the full spectrum of issues faced by people with […]